News

Nigeria receives over 1 million Meningitis vaccine doses to curb outbreak in North

Share on
0
Nigeria has received a shipment of over one million meningitis vaccine doses to tackle the ongoing outbreak in the North.
Over one million doses of the meningitis vaccine have been delivered to Nigeria to help control the outbreak in the northern region. Photo credit: Punch Newspapers.
  • Nigeria has received more than one million doses of the Men5CV vaccine to combat the meningitis outbreak in the northern region
  • The vaccination campaign will focus on individuals aged 1-29 years,  beginning in Kebbi and Sokoto states, with plans to extend to Yobe
  • As of March 26, 2025, Nigeria has reported 807 suspected cases of meningitis and 74 deaths, with a 9.2% case fatality rate across 22 states

The Federal Ministry of Health and Social Welfare has received more than one million doses of the pentavalent meningococcal conjugate vaccine (Men5CV) from the Gavi-funded global stockpile as part of urgent efforts to tackle the ongoing outbreak of meningitis serogroups C and W in northern Nigeria.

This development was announced on Friday, April 4, in a joint statement by the Vaccine Alliance (Gavi), the World Health Organisation (WHO), and the United Nations Children’s Fund (UNICEF).

According to the statement, the first shipment of vaccines will support the launch of an outbreak response campaign aimed at individuals aged one to 29 years, the group most affected by the outbreak. 

The campaign will begin in Kebbi and Sokoto States and is expected to expand to Yobe State as additional doses arrive.

As of March 26, 2025, the Nigeria Centre for Disease Control and Prevention (NCDC) has reported 807 suspected cases of cerebrospinal meningitis and 74 related deaths across 22 states. The case fatality rate currently stands at 9.2 per cent.

Speaking on the vaccine’s arrival, the Coordinating Minister of Health and Social Welfare, Prof. Muhammad Pate, described it as a significant step in Nigeria’s epidemic response efforts.

“This reflects our commitment under President Bola Ahmed Tinubu’s Renewed Hope Agenda to protect the health and well-being of Nigerians, especially children and young people who are most vulnerable,” he said.

Prof. Pate highlighted that through the Nigeria Health Sector Renewal Investment Initiative and the Sector-Wide Approach, the government is prioritising epidemic preparedness and rapid response. 

He also expressed gratitude to Gavi, WHO, and UNICEF for their swift support.

Meningitis, a severe infection of the protective membranes covering the brain and spinal cord, remains a pressing public health challenge. 

It can be caused by various pathogens, including bacteria, fungi, and viruses, but bacterial meningitis accounts for the majority of global cases, according to WHO.

UNICEF Representative in Nigeria, Cristian Munduate, emphasised the importance of protecting children from preventable diseases like meningitis.

“The arrival of the Men5CV vaccine is a crucial step in halting the current outbreak and safeguarding Nigeria’s most vulnerable, particularly children and young adults who are at greatest risk,” she said. 

Munduate also reaffirmed UNICEF’s commitment to supporting rapid vaccine deployment, community mobilisation, and strengthening immunisation systems in collaboration with national partners.

Echoing similar sentiments, WHO Country Representative in Nigeria, Dr. Walter Mulombo, praised the collaborative efforts that brought the Men5CV vaccine to Nigeria.

“From research to delivery, this vaccine is the result of strong partnerships between the Nigerian government, WHO, Gavi, and others. It’s not only essential for controlling the present outbreak but also a key element in securing Nigeria’s long-term health security,” he said.

Nigeria launches first phase of malaria vaccine rollout

Meanwhile, TheRadar earlier reported that the National Primary Health Care Development Agency (NPHCDA) announced that the first phase of the malaria vaccine rollout in Nigeria began on Monday, December 2, 2024. 

The vaccination campaign initially focused on Kebbi and Bayelsa state.

The initiative marked a significant step in the country’s efforts to combat malaria, a leading cause of morbidity and mortality in Nigeria.

Share on
avatar
Aishat Bolaji AjaoAdmin

Aishat Bolaji is a writer and lifestyle enthusiast. She loves to keep up with news, fashion, and lifestyle.

Comments ()

Share your thoughts on this post

Loading...

Similar Posts

Never get outdated, subscribe now.

By subscribing, you will get daily, insightful updates of what you need to know in the news, as regarding politics, lifestyle, entertainment and cryptocurrency. You can always cancel it whenever you wish.

Social:

Subscribe now.

Category